ADCY9 anticorps (C-Term)
Aperçu rapide pour ADCY9 anticorps (C-Term) (ABIN2196327)
Antigène
Voir toutes ADCY9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1294-1323, C-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- ADCY9, CT (ADCY9, KIAA0520, Adenylate cyclase type 9, ATP pyrophosphate-lyase 9, Adenylate cyclase type IX, Adenylyl cyclase 9)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- ADCY9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1294-1323 amino acids from the C-terminal region of human ADCY9.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- ADCY9 (Adenylate Cyclase 9 (ADCY9))
-
Autre désignation
- ADCY9
-
NCBI Accession
- NP_001107
-
UniProt
- O60503
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Antigène
-